Target intelligence / Profile preview

Glucose uptake pathway

Molecular classification
Other (molecular pathway), Includes Transporters (e.g., Glucose transporter type 1 (GLUT1), Glucose transporter type 4 (GLUT4)), Includes Receptors (Insulin receptor), Includes Signaling molecules (kinases, small GTPases)
01

Overview

The glucose uptake pathway describes the cellular process whereby glucose is transported from the bloodstream into cells, with insulin-stimulated glucose uptake being a pivotal example in skeletal muscle and adipose tissue. At the molecular level, this pathway involves extracellular insulin binding to the insulin receptor, activation of downstream signaling cascades such as IRS–PI3K–Akt, and facilitation of GLUT4 (and in some cells, GLUT1) translocation to the plasma membrane, enabling glucose entry[2][3][4][5]. In addition, insulin-independent pathways (including those activated by muscle contraction or other hormones such as isthmin-1) also stimulate glucose uptake via distinct, but sometimes overlapping, intracellular effectors[4][5]. Disruption of this pathway (such as defective GLUT4 translocation or insulin receptor signaling) is a major feature of type 2 diabetes, metabolic syndrome, and related disorders[4][5].

Other names
Glucose transport pathwayCellular glucose uptake pathwayInsulin-stimulated glucose uptake
02

Mechanism of action

Insulin and some drugs stimulate translocation of GLUT4 to the plasma membrane, increasing cellular glucose uptake[2][3][4][5]. Metformin increases insulin sensitivity and can enhance AMPK-dependent glucose uptake pathways. Thiazolidinediones upregulate GLUT4 and improve insulin sensitivity.

03

Biological functions

Glucose homeostasisSignal transductionMetabolic regulationCellular energy supply
04

Disease associations

Diabetes (types 1 and 2)Metabolic syndromeInsulin resistanceObesityCardiovascular disease
05

Safety considerations

Hypoglycemia risk due to excessive glucose uptake (especially with insulin, sulfonylureas)Off-target metabolic effects (insulin signaling affects multiple tissues)Rare risk of lactic acidosis (metformin)Fluid retention/heart failure risk (thiazolidinediones)Potential mitogenic effects (insulin and IGF pathways)
06

Interacting drugs

Insulin

4 more in the full profile.

07

Biomarkers

GLUT4 and GLUT1 expressionInsulin receptor phosphorylation statusBlood glucose and HbA1c (clinical proxies)Akt phosphorylation

Beyond the preview

Go deeper on Glucose uptake pathway.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glucose uptake pathway.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call